MedTrace Logo

Growth and Tolerance Trial on Infant Formula With HMO

NCT04066413 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2023-09-28

No results posted yet for this study

Summary

The aim of the study is to compare growth of healthy infants fed an infant formula supplemented with a human milk oligosaccharide to that of infants on standard formula.

Conditions

  • Healthy Growth

Interventions

OTHER

Standard infant formula

Standard infant formula

OTHER

Infant formula supplemented with HMO

Infant formula supplemented with HMO

Sponsors & Collaborators

  • FrieslandCampina

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
1 Month
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2023-01-26
Completion
2023-01-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04066413 on ClinicalTrials.gov